The National Institutes of Health yesterday awarded $12 million to non-profit research institution RTI International for outreach and engagement efforts in ethnic and racial minority communities that have been disproportionately affected by the COVID-19 pandemic. RTI will support teams in 11 states focusing on COVID-19 awareness and educational research among African American, Hispanic and Latinx, and American Indian communities through NIH’s Community Engagement Alliance (CEAL) Against COVID-19 Disparities.

CEAL, an NIH-wide effort led by the National Institute on Minority Health and Disparities and the National Heart, Lung, and Blood Institute, will leverage established relationships between NIH-funded researchers and local community-engaged leaders to help reach underserved communities. In addition, RTI will promote and facilitate these groups’ inclusion and participation in vaccine and therapeutic clinical trials to prevent and treat COVID-19.

In an April 16 letter to the Department of Health and Human Services, the AHA, American Medical Association, and American Nurses Association urged Secretary Alex Azar to “employ the resources of NIMHD…to research and develop approaches to specifically address the COVID-19 needs of minority populations.”

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…